|
[1]
|
Duggan, C., Dvaladze, A., Rositch, A.F., et al. (2020) The Breast Health Global Initiative 2018 Global Summit on Im-proving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and Overview. Cancer, 126, 2339-2352. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chen, L., Kong, X., Yan, C., Fang, Y. and Wang, J. (2020) The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer. Oncotargets and Therapy, 13, 1397-1412. [Google Scholar] [CrossRef]
|
|
[3]
|
Li, J., Yuan, M., Yang, L. and Guo, L. (2020) Correlation of Contrast-Enhanced Ultrasound Features with Prognostic Factors in Invasive Ductal Carcinomas of the Breast. Japanese Journal of Radiology, 38, 960-967. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Danforth, D.N. (2021) The Role of Chronic Inflammation in the Development of Breast Cancer. Cancers, 13, Article 3918. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Potempa, L.A., Rajab, I.M., Olson, M.E. and Hart, P.C. (2021) C-Reactive Protein and Cancer: Interpreting the Differential Bioac-tivities of Its Pentameric and Monomeric, Modified Isoforms. Frontiers in Immunology, 12, Article 744129. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kehm, R.D., McDonald, J.A., Fenton, S.E., et al. (2020) Inflam-matory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research. International Journal of Environmental Research and Public Health, 17, Article 5445. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kaur, R.P., Rubal, Banipal, R.P.S., Vashistha, R., Dhiman, M. and Munshi, A. (2019) Association of Elevated Levels of C-Reactive Protein with Breast Cancer, Breast Cancer Subtypes, and Poor Outcome. Current Problems in Cancer, 43, 123-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Arthur, R.S., Dannenberg, A.J. and Rohan, T.E. (2021) The Association of Prediagnostic Circulating Levels of Cardiometabolic Markers, Testosterone and Sex Hor-mone-Binding Globulin with Risk of Breast Cancer among Normal Weight Postmenopausal Women in the UK Biobank. International Journal of Cancer, 149, 42-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Robinson, T., Martin, R.M. and Yarmolinsky, J. (2020) Mendelian Ran-domisation Analysis of Circulating Adipokines and C-Reactive Protein on Breast Cancer Risk. International Journal of Cancer, 147, 1597-1603. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Soehnlein, O. (2019) Neutrophil Research, Quo Vadis. Trends in Immunol-ogy, 40, 561-564. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Cho, U., Park, H.S., Im, S.Y., et al. (2018) Prognostic Value of Sys-temic Inflammatory Markers and Development of a Nomogram in Breast Cancer. PLOS ONE, 13, e0200936. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Anwar, S.L., Cahyono, R., Avanti, W.S., Budiman, H.Y., Harahap, W.A. and Aryandono, T. (2021) Pre-Treatment Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Additional Markers for Breast Cancer Progression: A Retrospective Cohort Study. Annals of Medicine and Surgery, 63, Article ID: 102144. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Losada, B., Guerra, J.A., Malón, D., Jara, C., Rodriguez, L. and Del Barco, S. (2019) Pretreatment Neutrophil/Lymphocyte, Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutro-phil/Monocyte Ratios and Outcome in Elderly Breast Cancer Patients. Clinical and Translational Oncology, 21, 855-863. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Huszno, J., Kołosza, Z., Mrochem-Kwarciak, J. and Zajusz, A. (2020) Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients. Oncology, 98, 487-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wang, Y., Huang, G. and Li, Z. (2020) Prognostic Significance of In-flammatory Biomarkers in Patients with Breast Cancer Skeletal Metastases. Cancer Management and Research, 12, 11463-11475. [Google Scholar] [CrossRef]
|
|
[16]
|
Stoiber, D. and Assinger, A. (2020) Platelet-Leukocyte Interplay in Cancer Development and Progression. Cells, 9, Article 855. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhang, M., Huang, X.Z., Song, Y.X., Gao, P., Sun, J.X. and Wang, Z.N. (2017) High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis. Biomed Research International, 2017, Article ID: 9503025. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Morkavuk, Ş.B., Kocaöz, S. and Korukluoğlu, B. (2021) Diagnostic Value of Platelet/Lymphocyte Ratio (PLR) for Predicting Sentinel Axillary Lymph Node Positivity in Early-Stage Breast Cancer Compared with Ultrasonography. International Journal of Clinical Practice, 75, e14939. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Takada, K., Kashiwagi, S., Asano, Y., et al. (2020) Prediction of Sentinel Lymph Node Metastasis Using the Platelet-to-Lymphocyte Ratio in T1 Breast Cancer. Anticancer Research, 40, 2343-2349.
https://doi/org/10.21873/anticanres.14202
|
|
[20]
|
Goto, W., Kashiwagi, S., Asano, Y., et al. (2018) Predictive Value of Lymphocyte-to-Monocyte Ratio in the Preoperative Setting for Progression of Patients with Breast Cancer. BMC Cancer, 18, 1137.
https://doi/org/10.1186/s12885-018-5051-9
|
|
[21]
|
Hu, R.-J., Liu, Q., Ma, J.-Y., Zhou, J. and Liu, G. (2018) Pre-operative Lymphocyte-to-Monocyte Ratio Predicts Breast Cancer Outcome: A Meta-Analysis. Clinica Chimica Acta, 484, 1-6. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Ma, Y., Zhang, J. and Chen, X. (2021) Lympho-cyte-to-Monocyte Ratio Is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chem-otherapy. Cancer Management and Research, 13, 1571-1580.
https://doi/org/10.2147/CMAR.S292048
|
|
[23]
|
Yousefi, B., Sanaie, S., Ghamari, A.A., Soleimanpour, H., Karimian, A. and Mahmoodpoor, A. (2020) Red Cell Distribution Width as a Novel Prognostic Marker in Multiple Clinical Studies. Indian Journal of Critical Care Medicine, 24, 49-54. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yao, D., Wang, Z., Cai, H., Li, Y. and Li, B. (2019) Relationship between Red Cell Distribution Width and Prognosis in Pa-tients with Breast Cancer after Operation: A Retrospective Cohort Study. Bioscience Reports, 39.
https://doi/org/10.1042/BSR20190740
|
|
[25]
|
Sun, H., Yin, C.Q., Liu, Q., Wang, F. and Yuan, C.H. (2017) Clinical Significance of Routine Blood Test-Associated Inflammatory Index in Breast Cancer Patients. Medical Science Monitor, 23, 5090-5095.
https://doi/org/10.12659/msm.906709
|
|
[26]
|
Korniluk, A., Koper-Lenkiewicz, O.M., Kamińska, J., Kemona, H. and Dymicka-Piekarska, V. (2019) Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators of Inflammation, 2019, Article ID: 9213074. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Gu, M., Zhai, Z.H., Huang, L., et al. (2016) Pre-Treatment Mean Plate-let Volume Associates with Worse Clinicopathologic Features and Prognosis of Patients with Invasive Breast Cancer. Breast Cancer, 23, 752-760. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Mutlu, H., Eryilmaz, M.K., Musri, F.Y., Gunduz, S., Salim, D.K. and Coskun, H.S. (2016) Mean Platelet Volume as an Independent Predictive Marker for Pathologic Complete Response after Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer. Asian Pacific Journal of Cancer Prevention, 17, 2089-2092. [Google Scholar] [CrossRef]
|